TipRanks
Advertisement
Advertisement
AbbVie price target raised to $282 from $276 at BofA
PremiumThe FlyAbbVie price target raised to $282 from $276 at BofA
12d ago
AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS
Premium
The Fly
AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS
17d ago
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio
Premium
Company Announcements
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio
17d ago
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe FlyHHS plans to add FDA deputy roles for technology, drugs, CNBC says
26d ago
AbbVie price target raised to $303 from $298 at Piper Sandler
Premium
The Fly
AbbVie price target raised to $303 from $298 at Piper Sandler
1M ago
AbbVie Raises $9 Billion Debt to Fund Acquisition
Premium
Company Announcements
AbbVie Raises $9 Billion Debt to Fund Acquisition
1M ago
AbbVie prices $9.9B senior notes to fund acquisition
PremiumCompany AnnouncementsAbbVie prices $9.9B senior notes to fund acquisition
2M ago
AbbVie upgraded to Buy from Hold at Erste Group
Premium
The Fly
AbbVie upgraded to Buy from Hold at Erste Group
2M ago
AbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
Premium
The Fly
AbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100